Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis. [PDF]
Rostami-Afshari B +12 more
europepmc +1 more source
Efficacy and Safety of Vildagliptin Sustained-Release and Metformin Sustained-Release Fixed-Dose Combination in Indian Patients With Type 2 Diabetes Mellitus: A Real-World Perspective. [PDF]
Sarda A +9 more
europepmc +1 more source
Efficacy of Initial Basal-Supported Oral Therapy with Sitagliptin in Untreated Type 2 Diabetes [PDF]
core +1 more source
Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial. [PDF]
Yang X +7 more
europepmc +1 more source
Henoch-Schönlein purpura induced by sitagliptin: A case report. [PDF]
Moschella A, Kirshen C.
europepmc +1 more source
Reduced Weight Gain with Pioglitazone vs Vildagliptin in <i>CREBRF</i> rs373863828 A-allele Carriers: Insights from the WORTH Trial. [PDF]
Toomata ZLL +14 more
europepmc +1 more source
Gliptin-Induced Bullous Pemphigoid: Are Statins and Angiotensin Receptor Blockers the Cause? [PDF]
Beksac B +7 more
europepmc +1 more source
Bullous pemphigoid associated with vildagliptin in an elderly adult with diabetes mellitus. First case in Peru. [PDF]
Concepción-Zavaleta M +7 more
europepmc +1 more source
Eco-Friendly electrochemical sensor for vildagliptin detection in human plasma: green approach using ZnO nanoparticles and graphene oxide. [PDF]
Samy B, Mabrouk MM, Hamid MAA, Ahmed HM.
europepmc +1 more source
Can DPP-4 Inhibitors Improve Glycemic Control and Preserve Beta-Cell Function in Type 1 Diabetes Mellitus? A Systematic Review. [PDF]
Villa Chagas H +5 more
europepmc +1 more source

